Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical and Radiographic Success of MTA vs Biodentine
Sponsor: Geisinger Clinic
Summary
The purpose of this prospective study is to compare the clinical and radiographic success of MTA and Biodentine as a medicament in vital pulp therapy in maxillary and mandibular primary molars in a pediatric population. There is limited research currently on Biodentine since it's a novel product. Biodentine is less expensive than MTA and does not cause discoloration like MTA. Biodentine may be an alternative medicament used for vital pulp therapy in primary molars.
Official title: Clinical and Radiographic Success of Mineral Trioxide Aggregate (MTA) vs Septodont Biodentine in Primary Molars in Pulpotomy and Indirect Pulp Cap Treatments
Key Details
Gender
All
Age Range
2 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
646
Start Date
2021-11-12
Completion Date
2026-12-01
Last Updated
2025-12-23
Healthy Volunteers
Yes
Conditions
Interventions
Biodentine
During a patients procedure, one tooth will receive Biodentine instead of MTA.
mineral trioxide aggregate (MTA)
mineral trioxide aggregate (MTA)
Locations (1)
Geisinger
Danville, Pennsylvania, United States